Skip to content

Utilization of the Asthma Control Test at the initiation of therapy for patients with asthma

Utilization of the Asthma Control Test at the initiation of therapy for patients with asthma: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN31998214
Enrollment
100
Registered
2011-09-21
Start date
2011-09-10
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Respiratory Asthma

Interventions

Patients will be randomized to receive their initial treatment based on either the Saudi Initiative for Asthma (SINA) Approach (Group A) or the Global Initiative for Asthma (GINA) approach (group B).

Sponsors

King Abdullah International Medical Research Center (Saudi Arabia)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age above 12 years with the diagnosis of asthma 2. Literate patient 3. No controller therapy for 2 months

Exclusion criteria

Exclusion criteria: Use of controller therapy for 2 months

Design outcomes

Primary

MeasureTime frame
1. Step up or down of therapy 2. Change in asthma control test (ACT) 3. Change in peak expiratory flow (PEF) Measured at initiation visit then follow-up visit in 4 weeks time

Secondary

MeasureTime frame
Change in forced expiratory volume in 1 sec (FEV1), measured at initiation visit then follow-up visit in 4 weeks time

Countries

Saudi Arabia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 26, 2026